Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection

Einstein (Sao Paulo). 2020 Jun 3;18:eAE5793. doi: 10.31744/einstein_journal/2020AE5793. eCollection 2020.
[Article in En, Portuguese]

Abstract
in En , Portuguese

In December 2019, a series of patients with severe pneumonia were identified in Wuhan, Hubei province, China, who progressed to severe acute respiratory syndrome and acute respiratory distress syndrome. Subsequently, COVID-19 was attributed to a new betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 20% of patients diagnosed as COVID-19 develop severe forms of the disease, including acute hypoxemic respiratory failure, severe acute respiratory syndrome, acute respiratory distress syndrome and acute renal failure and require intensive care. There is no randomized controlled clinical trial addressing potential therapies for patients with confirmed COVID-19 infection at the time of publishing these treatment recommendations. Therefore, these recommendations are based predominantly on the opinion of experts (level C of recommendation).

RESUMO: Em dezembro de 2019, uma série de pacientes com pneumonia grave foi identificada em Wuhan, província de Hubei, na China. Esses pacientes evoluíram para síndrome respiratória aguda grave e síndrome do desconforto respiratório agudo. Posteriormente, a COVID-19 foi atribuída a um novo betacoronavírus, o coronavírus da síndrome respiratória aguda grave 2 (SARS-CoV-2). Cerca de 20% dos pacientes com diagnóstico de COVID-19 desenvolvem formas graves da doença, incluindo insuficiência respiratória aguda hipoxêmica, síndrome respiratória aguda grave, síndrome do desconforto respiratório agudo e insuficiência renal aguda e requerem admissão em unidade de terapia intensiva. Não há nenhum ensaio clínico randomizado controlado que avalie potenciais tratamentos para pacientes com infecção confirmada pela COVID-19 no momento da publicação destas recomendações de tratamento. Dessa forma, essas recomendações são baseadas predominantemente na opinião de especialistas (grau de recomendação de nível C).

MeSH terms

  • Betacoronavirus*
  • Checklist
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / therapy
  • Critical Illness
  • Humans
  • Intensive Care Units / standards*
  • Pandemics
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / therapy
  • Practice Guidelines as Topic
  • Respiration, Artificial / methods
  • Respiration, Artificial / standards*
  • Severe Acute Respiratory Syndrome / diagnosis
  • Severe Acute Respiratory Syndrome / therapy

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2